About Getz Pharma

A Market Leader with Heart

The search for optimum human health
is the main driver at Getz Pharma. In
its effort to foster well-being in the
communities it serves, Getz Pharma
enhances the quality of life through
research and development,
manufacturing and marketing of
pharmaceutical, biotechnology and
health care products.

Getz Pharma establishes its brand

image through a robust and agile
marketing and sales presence in South
Asia, Central Asia, Southeast Asia,
Asia-Pacific, the Middle East and Africa.
IMS rates Getz Pharma as the fastest-
growing company in the regions it markets its products.

The fact that our products are well-accepted and their demand is
growing in these countries is because of the confidence imposed
in their quality by the medical community and patients, globally.

World-Class and cGMP-Compliant Manufacturing

We manufacture high-quality branded generics, that are leaders
in their class, at our cGMP-compliant facility in Pakistan.
Licensors, molecule owners and inventors from around the world
avail our toll manufacturing and/or licensing services.

Our Corporate Heritage

Getz Pharma is a member of the Getz Group of Companies. Getz
Brothers & Co. Inc. has operations in 23 countries, primarily in
Asia and Australia. Getz Brothers International distributes
consumer products, pharmaceutical products and medical devices
in these countries.

Business Partnerships
Getz Pharma puts a premium on developing associations with
companies that are committed with passion and ethics in one or
more of the following areas: contract research, contract
development; manufacturing; marketing; or distributing
pharmaceutical, biotechnology and health care products.

Human Resource Development and Corporate Culture

The key to ensure quality of the products and maintain our
market leadership is to develop the quality of our people. One of
Getz Pharma's key objectives is to ensure that Getz Pharma is
rated by its employees as one of the best companies to work for
in every country in which we operate. Respect for people, respect
for our business associates and customers, a focus on safe
technology, teamwork and transparency are the core values upon
which we build our corporate culture. We aspire to stay agile,
year after year, by creating a vision-driven organization that
continuously strives to empower its people. As a result, our
people have very high energy levels and they set very high goals
for themselves for which they feel fulfilled and are rewarded.

Socially Conscious Company

Good corporate citizenship is top-of-mind at Getz Pharma. We
engage in disease prevention initiatives, and conduct free
screening camps for Diabetes, Hepatitis, and other life-
threatening diseases. This way we maintain an unwavering focus
on the well-being of every community in every region in which we
operate.

Strengths

Smooth Governmental Interface

Getz Pharma has a highly skilled, effective and successful
regulatory team in every market that we operate in. Our
regulatory team ensures early product registrations in our
markets.

Research & Development 

Getz Pharma has robust new product development. A highly
qualified and trained team of scientists, pharmacists, chemists
and engineers in our Research & Development and operational
departments are working not only to develop new products but
also to have a continuous improvement in quality at a dedicated
high-tech R&D site. The products developed by this team conform
over their shelf life to internationally accepted standards of
quality, purity, efficacy and safety.

Brand Leader in Eleven Molecules

Getz Pharma is brand leader in eleven molecules in the areas of
Hepatology, Gastroenterology, Cardiovascular and Diabetes,
Pulmonary ENT & Chest, Rheumatology, and Infectious Diseases.

Getz Pharma Pakistan

Getz Pharma (Private) Limited has its head office in Dubai, UAE,
and plant operations based in Karachi, Pakistan. Getz Pharma,
which is the largest branded generic pharmaceutical company in
Pakistan, started its operations in 1995. Since its inception, Getz
Pharma has shown unparalleled growth both in qualitative as well
as quantitative aspects. According to the IMS, Getz Pharma was
ranked 195th out of 200 pharma companies in Pakistan in the
year 1995, but in just 14 years, Getz Pharma has achieved the
sixth position among 650 pharmaceutical companies and has
been recognized as one of the fastest-growing pharma firms in
Pakistan. During the last five years, the average growth rate of
Getz Pharma has been 45 percent, as compared to the Pakistan
pharma industry's average growth rate of 12 percent for the
same period. With the current pace, Getz Pharma is destined to
become the third-largest pharma company in Pakistan by the
year 2010. Currently, more than 900 people are working in the
sales and marketing alone – making Getz Pharma one of the
largest pharma companies in terms of human resources in sales
and marketing.

Getz Pharma is considered the leading pharmaceutical company

in terms of manufacturing and marketing experience. Getz
Pharma has a well-entrenched leadership position with major
shares in hepatology, gastroenterology, diabetology, cardiology
and infertility, as well as a strong presence in the following
therapeutic areas:

 Pulmonology
 Orthopedics
 Rheumatology
 Infectious diseases
 Pediatrics
 ENT

A large number of Getz Pharma brands hold market leadership in

their respective classes, including Uniferon and Risek, which are
the sixth and 15th largest brands, respectively, in the entire
pharma industry in Pakistan. The following brands are market
leaders in their respective classes:
 Generic Name Getz Pharma
Brand
Interferon Uniferon

Ribavirin Ribazole

Mesalamine Asacol

Atorvastatin Lipiget

Omeprazole Risek

Esomeprazole Nexum

Levofloxacin Leflox

Celecoxib Celbexx

Terresteris Tribulus
Gonadil-f
Comb

Fexofenadine Fexet

Candesartin Advant

Rosuvastatin Rovista

Glimepiride Getryl

Pregabalin Gabica

We aim to continue rapid growth in Pakistan by aggressively

launching new brands, entering new therapeutic segments, and
driving existing brands to market leadership positions. Our vision
is to become the third-largest pharmaceutical company in the
Pakistan by 2010.

Getz Pharma is associated with Muller & Phipps, the largest

distribution company in Pakistan, with an extensive distribution
network in 23 locations throughout Pakistan, with a coverage of
33,000 retail outlets.

Research & Development

At Getz Pharma, our new product development program generally
includes pre-formulation studies, excipient compatibility studies,
analytical methods development and validation, formulation
development and optimization, formal stability studies, and
manufacturing process development according to ICH Guidelines.
At Getz Pharma, we also have a quality program dedicated to
continuous improvement of product quality of running products at
a dedicated high-tech R&D site.

These laboratory-scale batches are subjected to stability as per

the ICH norms. The complete documentation of the laboratory
data is presented in a format compliant with European standards
or in an FDA-compliant mode, depending on the targeted
markets.

Getz Pharma also has research capabilities specializing in the

design, testing and evaluation of health care products for life
sciences companies worldwide. Our technology development
team consists of scientists drawn from some of the best research
organizations. Through a combination of state-of-the art
analytical instrumentation, infrastructure meeting global
development standards, and world-class expertise and level of
scientific excellence, we ensure that our clients receive true
added value to their R&D projects, completed in the speediest
and most cost-effective manner without compromising data
quality.
At Getz Pharma, we understand that a sound infrastructure
meeting global standards is an essential part of achieving our
deliverables. Our laboratories are well-equipped to handle:

 Tablets, immediate release

 Tablets, controlled or sustained-release including MUPs
 Tablets, enteric coated
 Capsules, hard gelatin or HPMC, filled with powder,
granules, mini tablets or pellets
 Capsules, controlled or sustained-release
 Oral liquids and suspensions
 Ocular drops, nasal sprays and inhalations
 Semi-solid dosage forms
 Injectable dosage forms including lyophilized products
 An ICH-compliant stability management program for testing
stability

Business Partnerships
Getz Pharma puts a
premium on developing
collaborations with like-
minded companies with
values and business
strategies similar to Getz
Pharma's for the
eradication of disease.

Molecule Holders,
Licensors and
Distributors with
relationships in Europe,
South America, North
America, Japan, China
and other large markets
can access vast
untapped markets in South Asia, Central Asia, Southeast Asia,
Asia-Pacific, the Middle East and Africa that comprise our
regions of operation.

Our business partners receive end-to-end solutions for their

operations.

We ensure:

 Regulatory management and registration of

pharmaceutical products with the respective FDAs and
Ministries of Health
 A creative and dynamic marketing team in each country of
operation
 A highly passionate and proactive sales team in each
country of operation
 Healthy financials, efficient supply chain and information
systems
 Effective and robust distribution

Who we are
Getz Pharma manufactures and markets pharmaceutical,
biotechnology and health care products. Most of the brands that
we market are brand leaders in the countries where we
operate. 
About Getz Pharma.

What we do
We develop, formulate and manufacture world-class branded
generics, develop drug dossiers, manage registration of
pharmaceutical products, engage in contract research and
development, B2B partnerships, and offer marketing, sales and
distribution in our regions of operation.

Why we are best in class

Giving our partners the results they seek takes agility, passion
and a spirit of continuous improvement. We are known to excel
in every aspect of our operations that range
fromManufacturing to Marketing; Systems to Sales; Qualit
y Control to Corporate Social Responsibility.

We offer:

 Regulatory compliance, and compliance to world-class GMP

and quality.
 Experience in bio-equivalence (B/E) studies at FDA-
validated laboratories as well as B/E in several Asian
countries.
 An experienced regulatory affairs team in every country of
operation.
 Systems to monitor daily/weekly/monthly sales and a field
force reporting system.
 Rapid growth in several regional markets, with our brands
as market leaders.

Making the world a better place

Our numbers show we are a dynamic company that delivers
results to its business partners. The thought remains that we
are in the noble profession of restoring health and saving lives.
A humbling thought that motivates us, and is the basis of
everything we do. If people breathe easier, sing louder and live
longer, then we gain the priceless satisfaction of playing our
part in making the world a better place.

Compare Getz Pharma's annual growth with that of the total

pharmaceutical market in our regions of operation and it
becomes evident that we are best in class.
Marketing & Sales

Guiding Principles
Getz Pharma's marketing philosophy
is to offer quality products that are
bioequivalent to the leader, at prices
that are affordable to a diverse cross-
section of the community, with a
focus on scientific information
dissemination. Being socially
responsible and adding value to the
medical community is an integral part
of our philosophy.

Ensuring Outcomes
Getz Pharma marketing strategies
are an ideal mix of public awareness
campaigns, disease awareness and
prevention campaigns, scientific
promotion, and customer relationship management.

Expanding Overseas
In the international market, Getz Pharma's objective is to
achieve a position of leadership in every molecule within three
years of launch in every market. Future plans lay a strong
emphasis on showing the flag in new geographical areas with
special regard to countries in the Asia Pacific, Central Asia, the
African Markets and the Middle

Brand Leader
We are brand leaders in most of the therapeutic segments in
each country in which we operate.

Fastest Growth
Getz Pharma has been rated by the IMS as the fastest-growing
pharmaceutical company in Pakistan, the Philippines, Vietnam
and Sri Lanka. In several markets where we have entered
recently, we are likely to be rated as the fastest-growing
company by the end of 2009.

Technical Operations
Manufacturing & Quality Assurance

Getz Pharma is a world-class

producer of branded generic
pharmaceutical products. Getz
Pharma produces specialty products
at its state-of-the-art formulation
plant. These include solid and liquid
oral dosage forms (tablets, capsules,
syrups, suspensions and dry
powder), and injections (sterile liquid
vials, sterile liquid ampoules, sterile
dry powders and sterile lyophilized
powders).

A highly qualified and trained team of

scientists, pharmacists, chemists and
engineers work in our Research &
Development and Operations departments, developing new
products in an environment that celebrates continuous
improvement in quality.

Our manufacturing site has the latest analytical instruments.

We monitor quality assurance through quality systems that
ensure the consistent quality of our products.

Our facilities comply with cGMP and WHO standards, and have
consistently scored high with the regulatory compliance.

The fact that our products are well-accepted and their demand
is growing globally reflects the confidence in their quality by the
medical community of doctors and patients.

Regulatory Affairs

Our diversified and extensive experience allows us to submit

high-quality dossiers and get the application right the first time.
As a result, our products are registered in more than 30
countries.

Getz Pharma has an experienced regulatory affairs team in each

of the regions where we operate to ensure quick approvals of
new products from the respective FDA/Ministry of Health of
each country. Our teams are qualified to handle all the scientific
disciplines required for the successful registration of new
products in different territories.

Warehouse

Good Storage Practices (GSP) at Getz Pharma:

Getz Pharma has a world-class, state-of-the-art, automated,

high-rise, temperature-controlled pharmaceutical warehouse.
This warehouse meets WHO and U.S. FDA guidelines for Good
Storage Practices (GSP). This warehouse optimizes space
utilization in a covered area of 800,000 cubic feet and is
equipped with two VNA (Very Narrow Aisle) Tri Lateral Stackers
with computerized and automated guidance systems that
control speed based on the load height and steering angle to
travel within the aisles.

The warehouse has temperature monitoring and proper

validated logging system with 24-hour, round-the-clock backup
generators to ensure the maintenance of the required storage
conditions. The facility is also equipped with beam detectors
and a water sprinkler system for fire fighting.

Storage for Cold Chain Products

Temperature-sensitive products need extra vigilance for

maintenance of storage conditions. The U.S. FDA and WHO
have stringent specifications for the design and construction of
storage space for cold chain products. Catering to this critical
aspect, Getz Pharma's warehouse also houses cold storage
space for temperature-sensitive products.
Getz Pharma's Cold Storage space is 2624 cubic feet where
temperature is maintained at 2° C - 8° C. This Cold Storage
facility is equipped with a temperature chart recorder, digital
thermometer, backup generator and hooters to ensure the
requisite vigilance. Calibrated devices are set on the
temperature between 2° C - 8° C and in the unlikely event of
the temperature trend goes out of the specified limits, an alarm
sets off and sends the signals to the maintenance engineers
who are equipped to rectify the system within minutes. This
system is operational and functional 24 hours a day, 365 days a
year.

Products

Analgesic

Vie
Generic w
Indication Brands Form
Name Det
ail

Piroxicam- It is indicated for Nysa  Tablets Vie

beta- variety of acute w
cyclodextrin painful
conditions
requiring anti-
inflammatory
and analgesic
 activity,
including
rheumatoid,
osteo-arthritis
(arthrosis
degenerative
joint disease),
ankylosing
spondylitis,
musculoskeletal
and joint
disoders, gout,
in soft-tissue
disoders and in
post-operative
pain.

Anti-asthmatics

Vie
Generic w
Indication Brands Form
Name Det
ail

Beclomethason Indicated in the Bekson  Inhaler Vie

e dipropionate prophylactic Bekson w
management of Forte 
mild, moderate,
or severe
asthma in adults
or children.

Ipratropium Indicated for the Optra  Aerosol Vie

bromide maintenance Inhaler w
treatment of Solution
bronchospasm
associated with
chronic
 obstructive
pulmonary
disease,
including chronic
bronchitis and
emphysema.

Montelukast For the Montige Granules Vie

sodium prophylaxis and t  Tablets w
chronic
treatment of
asthma and
allergic rhinitis

Salbutamol Indicated for the Salbo  Inhaler Vie

routine Solution w
management of
chronic
bronchospasm
unresponsive to
conventional
therapy; the
treatment of
acute severe
asthma.

Salbutamol + Indicated for the Xaltide  Inhaler Vie

Beclomethason long-term w
e dipropionate management of
asthma only
when the need
for inhaled
corticosteroid
and
bronchodilator
therapy has
been
established.
Anti-coagulants

Vie
Generic w
Indication Brands Form
Name Det
ail

Clopidogrel Indicated for the Norplat  Tablets Vie

reduction of w
thrombotic
events in
patients with
recent
myocardial
infarction,
recent stroke or
established
peripheral
arterial disease.

Clopidogrel + It is indicated for Norplat Tablets Vie

Aspirin thereduction of -S  w
thrombotic
events in
patients with
recent
myocardial
infarction,
recent stroke,
established
peripheral
arterial disease,
acute coronary
syndrome(unsta
ble angina/non-
Q-wave MI)

Anti-Convulsant
 Vie
Generic w
Indication Brands Form
Name Det
ail

Gabapentin It is indicated for Gabix  Capsules Vie

various types of Mirgy  w
neuropathic pain
in adults (a)
Postherpetic
neuralgia (PHN),
(b) Peripheral
diabetic
neuropathies.
(c) Trigeminal
neuralgia. It is
indicated as
adjunctive
therapy in the
treatment of
partial seizures
with and without
secondary
generalization in
patients over 12
years of age
with epilepsy. It
is also indicated
as adjunctive
therapy in the
treatment of
partial seizures
in paediatric
patients age 6-
12 years.

Pregabalin It is indicated Gabica  Capsules Vie

 (a) for the w
management of
neuropathic pain
associated with
diabetic
peripheral
neuropathy (b)
post herpetic
neuralgia (c) as
adjunctive
therapy in adults
with partial
seizures with or
without
secondary
generalization
(d) for the
treatment of
generalized
anxiety disorder
(GAD) in adults
(e) for the
treatment of
fibromyalgia
syndrome
(FMS).

Anti-depressant

Vie
Generic w
Indication Brands Form
Name Det
ail

Escitalopram It is indicated for Zavesc Tablets Vie

the treatment of a  w
(a) Major
 depressive
episodes (b)
Panic disorder
with or without
agoraphobia. (c)
Social anxiety
disorder (d)
Generalized
anxiety disorder
(e) Obsessive-
compulsive
disorder.

Anti-diabetic

Vie
Generic w
Indication Brands Form
Name Det
ail

Gliclazide Indicated for Getzid Tablets Vie

non-insulin MR  w
dependent
diabetes (type
II) in adults
when dietary
measures,
physical exercise
and weight loss
alone are not
sufficient to
control blood
glucose.

Glimepiride An adjunct to Getryl  Tablets Vie

diet and exercise Getzgli w
to lower blood m 
glucose in
 patients with
non insulin-
dependent (type
2) diabetes
mellitus.

Glimepiride + It is indicated as Getfor Tablets Vie

MetforminHCl an adjunct to min  w
diet and exercise
to improve
glycemic control
in patients with
type 2 diabetes
whose diabetes
is not
adequately
controlled with
glimipride or
metformin Hcl
alone, or for
those patients
who have
initially
responded to
glimipride or
metformin Hcl
alone and
required
additional
glycemic control.

Human insulin It is indicated for Diamisu  Vial Vie

rDNA origin the treatment of w
Diabetes Mellitus Insuget 
type I, Diabetes
Mellitus type II
either alone or
in combination
 with oral anti-
diabetic agents.
Patients with
gestational
diabetes. It is
also used for the
emergency
management of
diabetic
ketoacidosis.

Pioglitazone For the Pioglite  Tablets Vie

treatment of Zolid  w
Type 2 diabetes
mellitus
(NIDDM) or
adult onset
diabetes.

Pioglitazone + It is indicated as Zoliget  Tablets Vie

Glimepiride an adjunct to w
diet and exercise
to improve
glycemic control
in patients with
type 2 diabetes.

Pioglitazone + It is indicated as Pioglite Tablets Vie

Metformin HCl an adjunct to Plus  w
diet and exercise Zolid
to improve Plus 
glycemic control
in patients with
type 2 diabetes
mellitus who are
already treated
with pioglitazone
alone or who are
 not adequately
controlled on
metformin
alone, or for
those patients
who have
initially
responded to
pioglitazone
alone and
require
additional
glycemic control.

Anti-hypertensive

Vie
Generic w
Indication Brands Form
Name Det
ail

Amlodipine It is indicated for Amlo  Tablets Vie

Besilate (a) Treatment of Amloge w
hypertension. t 
(b) Treatment Lopicar
and prophylaxis d 
of chronic stable
angina pectoris.
(c) Treatment of
confirmed or
suspected
vasopastic
angina

Candesartan For the Advant  Tablets Vie

cilexetil treatment of Atasart  w
Hypertension. It
may be used
 alone or in
combination
with other anti-
hypertensive
agents.

Candesartan For the Advant Tablets Vie

cilexetil + treatment of ec  w
Hydrochlorothi Hypertension. Atasart
azide H 

Carvedilol It is indicated for Xicard  Tablets Vie

the treatment of w
essential
hypertension,
left ventricular
dysfunction
following
myocardial
infarction,
chronic stable
angina and
unstable angina
and
symptomatic
patients with
stable, mild,
moderate and
severe chronic
heart failure.

Lisinopril Used alone or in Trupril  Tablets Vie

combination w
with other
medication to
treat high blood
pressure.
Lisinopril + Indicated in the Co- Tablets Vie
Hydrochlorothi management of Trupril  w
azide mild to
moderate
hypertension in
patients who are
not adequately
controlled on
monotherapy.

Nebivolol For the Nebil  Tablets Vie

treatment of: w
Essential
hypertension
and stable mild
and moderate
chronic heart
failure in
addition to
standard
therapies in
elderly patients.

Telmisartan It is indicated for Tasmi  Tablets Vie

the treatment of w
essential
hypertension. It
may be used
alone or in
combination
with other anti
hypertensive
agents.

Telmisartan+ It is indicated for CoTasm Tablets Vie

Hydrochlorothi the treatment of i  w
azide hypertension.
Anti-infertility

Vie
Generic w
Indication Brands Form
Name Det
ail

Tribulus Indicated for the Gonadil Capsules Vie

Terrestris treatment of -f  w
Vitamin-E, L- male sexual
Opti Zinc, health problems
Selenium and fertility
disorders.

Anti-Inflammatory (Intestinal)

Vie
Generic w
Indication Brands Form
Name Det
ail

Mesalazine Indicated in Asacol  Tablets Vie

conditions like w
Ulcerative Colitis
and Crohn\'s
Disease.

Anti-lipidemic

Vie
Generic w
Indication Brands Form
Name Det
ail

Atorvastatin Indicated in Lipiget  Tablets Vie

conditions like w
Homozygous
Familial
 Hypercholesterol
emia, Primary
Hypercholesterol
emia,
Hyperlipoprotein
emia and
Hypertriglycerid
emia

Atorvastatin + It is indicated as LipigetE Tablets Vie

Ezetimibe adjunctive Z  w
therapy to diet
for the reduction
of elevated
total-C, LDL-C,
Apo B in
patients with
primary
hypercholesterol
emia and with
HoFH as an
adjunct to other
lipid-lowering
treatments or if
such treatments
are unavailable.

Ezetimibe Adjunct to diet Ezita  Tablets Vie

in primary Ezitoget  w
hypercholesterol
emia,
homozygous
familial
hypercholesterol
emia.
Combination
therapy with
HMG-CoA
 reductase
inhibitors.

Fenofibrate It is indicated as Fenoget  Capsules Vie

adjunctive w
therapy to diet Fenoget
for the reduction z 
of LDL-C, Total-
C, Triglycerides
and Apo B in
adult patients
with primary
hypercholesterol
emia or mixed
dyslipidemia
(Fredrickson
Type IIa and
IIb). Fenoget is
indicated as
adjunctive
therapy to diet
for the
treatment of
adult patients
with
hypertriglyceride
mia (Fredrickson
types IV and V
hyperlipidemia).

Rosuvastatin Indicated in Richstat Tablets Vie

conditions like in  w
Homozygous Rovista 
Familial
Hypercholesterol
emia, Primary
Hypercholesterol
emia,
 Hyperlipoprotein
emia and
Hypertriglycerid
emia .

Anti-Malarial

Vie
Generic w
Indication Brands Form
Name Det
ail

Artemether + Used to treat Arthege Oral Vie

Lumefantrine uncomplicated t  Suspension w
infections with Arthege Tablets
plasmodium t DS 
falciparum, Arthege
including t EZ 
multidrug Arthege
resistant strains t
in adult, children Junior 
and infants of
5kg and above.

Anti-obesity

Vie
Generic w
Indication Brands Form
Name Det
ail

Orlistat It is indicated for Orlifit  Capsules Vie

obesity w
management
including weight
loss and weight
maintanance
when used in
 conjunction with
a reduced-
calorie diet.

Sibutramine For the Getlite  Capsules Vie

management of Nobese  w
obesity including
weight loss and
weight
maintenance
when used in
conjunction with
a reduced
calorie diet.

Anti-osteoporotic

Vie
Generic w
Indication Brands Form
Name Det
ail

Alendronate For the Alenta  Tablets Vie

Sodium prevention and Reventa  w
treatment of
osteoporosis.

Glucosamine For the Carsami Tablets Vie

Sulphate + treatment of n Plus  w
Chondroitin mild to Cartige
Sulphate moderate n Plus 
osteoarthritis
(OA)

Anti-retroviral

Generic Indication Brands Form Vie

Name w
 Det
ail

Tenofovir Tenofo-B is Getino Tablets Vie

disoproxil prescribed in B  w
fumarate combination Tenofo-
with at least two B 
other
antiretroviral
agents for the
management of
HIV-infected
adults.It is used
in the treatment
of chronic
hepatitis B in
adults with
compensated
liver disease
with evidence of
active viral
replication;
persistant
elevated serum
alanine
aminotransferas
e (ALT) level
and histological
evidence of
active
inflammation
and fibrosis.

Anti-rheumatic

Generic Indication Brands Form Vie

Name w
 Det
ail

Celecoxib For symptomatic Celbexx  Capsules Vie

treatment of w
osteoarthritis Celbexx
(OA), Plus 
rheumatoid Celcoxx 
arthritis (RA)
and ankylosing
spondyliltis.

Diclofenac A treatment for Panslay  Injection Vie

Sodium pain and Tablets w
inflammation
arising from
arthritis, gout or
rheumatic
diseases.

Diclofenac A combination Cytopa Tablets Vie

Sodium + product with GI n  w
Misoprostol safety for the
treatment of
pain and
inflammation
associated with
arthritis, gout or
rheumatic
diseases.

Hydroxychloro It is indicated for HCQ Tablets Vie

quine Sulfate the treatment 200  w
of: Acute and
Chronic
rheumatoid
arthritis, Mild
systemic and
 discoid lupus
erythematosus.
HCQ 200 is also
indicated for the
suppression and
treatment of
malaria. HCQ
has also been
used in the
treatment of
light-sensitive
skin eruptions.

Anti-Spasmodic

Vie
Generic w
Indication Brands Form
Name Det
ail

Mebeverine It is indicated for Mebeve Capsules Vie

HCl (IBS) Irritable r MR  w
Bowel Syndrome
in its primary
form,associated
with spasmodic
pain of G.I.
tract, diarrhoea
and
constipation.

Anti-ulcerants (Proton Pump Inhibitors)

Vie
Generic w
Indication Brands Form
Name Det
ail
Esomeprazole It is indicated for Esome  Capsules Vie
short term of Nexum  IV w
gastro- Nexum
esophageal IV 
reflux disease in
patients with
esophagitis
and /or severe
symptoms of
reflux, healing of
gastric ulcers
associated with
NSAID therapy,
prevention of
gastric and
duodenal ulcers
associated with
NSAID therapy
in patients at
risk. Note:
Nexum IV is
indicated for
above
indications when
oral
administration is
not possible.

Omeprazole It is indicated for Getzom Capsules Vie

diseases such e  Infusion w
as: gastro- Risek  Injection
esophageal IV
reflux, peptic
ulcer,
prophylaxis of
NSAID
associated
 ulceration,
Zollinger-Ellison
syndrome,
prophylaxis of
acid aspiration,
dyspepsia. Note:
Risek IV is
indicated for
above
indications when
oral
administration is
not possible.

Omeprazole + RISEK INSTA Risek Sachets Vie

Sodium powder for oral Insta  w
bicarbonate suspension is
indicated for:
For the
treatment of
heart burn and
other symptoms
associated with
GERD; for the
treatment of
erosive
esophagitis
which has been
diagnosed by
endoscopy;
short term
treatment of
active duodenal
ulcer; short term
treatment of
active benign
gastric ulcer; for
 maintenance
treatment of
healing of
erosive
esophagitis; for
reduction
treatment of risk
of upper
gastrointestinal
bleeding in
critically ill
patients.

Rabeprazole It is indicated for Promto  Tablets Vie

Sodium the treatment of w
the following.
(a) Acute
duodenal ulcer.
(b) Acute benign
gastric ulcer. (c)
Symptomatic
Erosive or
Ulcerative
Gastroesophage
al Reflux
Disease (GERD).
(d)
Gastroesophage
al Reflux
Disease Long-
term
Management
(GERD
Maintenance).
(e) Zollinger-
Ellison
Syndrome. (f)
 For the
eradication of
Helicobacter
pylori in patients
with peptic ulcer
disease in
combination
with appropriate
antibacterial
therapeutic
regiments.

Anti-virals

Vie
Generic w
Indication Brands Form
Name Det
ail

Ribavirin Broad spectrum Ribazol Capsules Vie

oral anti-viral e  Syrup w
product for the Tablets
treatment of
Hepatitis C in
combination
with
recombinant
interferon-Alfa

Antibiotics

Vie
Generic w
Indication Brands Form
Name Det
ail

Azithromycin It is indicated for Azoget  Capsules Vie

the treatment Zetro  Oral w
of: Upper and Suspension
lower respiratory Tablets
tract infections;
Uncomplicated
skin and skin
structure
infections;
Sexually
transmitted
diseases
(uncomplicated
urethritis and
cervicitis); Pelvic
inflammatory
disease in
patients who
require initial
intravenous
therapy;
Chlamydia
trachomatis
conjunctivitis
and trachoma in
adults and in
children 12
months or older;
Prevention of
infection due to
Mycobacterium
avium-
intracellulare
Complex (MAC)
disease in adults
and children
aged more than
12 years.”
Cefixime It is indicated in Cefiget  Capsules Vie
the treatment of DS w
the following Suspension
infections when Suspension
caused by Tablets
susceptible
strains of the
designated
microorganisms.
Uncomplicated
urinary tract
infections, Otitis
media,
Pharyngitis and
tonsillitis, Acute
bronchitis and
acute
exacerbations of
chronic
bronchitis,
uncomplicated
gonorrhea
(cervical/Urethra
l).

Ciprofloxacin It is indicated for Getcipr IV Vie

the treatment of o  Tablets w
following
infections
caused by
sensitive
bacteria:
Respiratory tract
infections, ENT
infections,
Urinary tract
infections, Skin
 and soft tissue
infections, Bone
and joint
infections,
Complicated
intra-abdominal
infections,
Infections of the
biliary tract,
Gastro intestinal
infections, Pelvic
inflammatory
diseases, Severe
systemic
infections,
Gonorrhea,
Complicated
urinary tract
infections and
pyelonephritis
inchildren and
adolescens
andInhalational
anthrax in adults
and children.

Clarithromycin Indicated for the Clariget  Drops Vie

treatment of Granules w
mild to Clariget Tablets
moderate OD 
infections such Claritek 
as
Pharyngitis/Tons Claritek
illitis, Acute XL 
maxillary
sinusitis, Acute
bacterial
 exacerbation of
chronic
bronchitis,
Community-
Acquired
Pneumonia,
Uncomplicated
skin and skin
structure
infections and
along with
omeprazole also
indicated for the
treatment of
patients with an
active duodenal
ulcer associated
with H.pylori
infection.

Doxycycline Used to treat Etidoxin  Capsules Vie

Hyclate many different w
bacterial
infections, such
as urinary tract
infections, acne,
gonorrhea, and
chlamydia,
periodontitis
(gum disease),
and others.

Levofloxacin Broad spectrum Getzlox  IV Vie

antibiotic for the Tablets w
treatment of Leflox 
bacterial Levocin 
infections such
as pneumonia,
 chronic
bronchitis and
sinusitis, urinary
tract infections
and skin
infections.

Moxifloxacin It is indicated for Getmox IV Vie

the treatment of y  Tablets w
following Moxiget 
bacterial
infections. (a)
Acute bacterial
sinusitis (b)
Acute bacterial
exacerbation of
chronic
bronchitis. (c)
Community
acquired
pneumonia. (d)
Un-complicated
skin and skin
structure
infections. (e)
Complicated skin
and skin
structure
infections

Ofloxacin It is indicated for Getzaci Tablets Vie

the treatment of n  w
adults with mild
to moderate
infections
caused by
susceptible
strains of the
designated
microorganisms
in the following
infections. (a)
Acute bacterial
exacerbations of
chronic
bronchitis. (b)
Community
acquired
Pneumonia. (c)
Uncomplicated
skin and skin
structure
infections. (d)
Acute,
uncomplicated
urethral and
cervical
gonorrhea (e)
Nongonococcal
urethiritis and
cervicitis (f)
Mixed infections
of the urethra
and cervix (g)
Acute pelvic
inflammatory
disease
(including
severe
infection). (h)
Uncomplicated
cystitis (i)
Complicated
urinary tract
infections. (j)
 Prostatitis

Antihistaminic and Antiallergic

Vie
Generic w
Indication Brands Form
Name Det
ail

Desloratadine It is indicated for Desloge Tablets Vie

(a) Seasonal t  w
allergic rhinitis Larinex 
(b) perennial
allergic rhinitis
(c) Chronic
idiopathic
urticaria

Fexofenadine A non-sedative Fexet  Tablets Vie

HCl antihistamine for w
treatment of
symptoms
associated with
seasonal allergic
rhinitis and
urticaria.

Fexofenadine A non-sedative Fexet Tablets Vie

HCl + antihistamine D  w
Pseudoephedri combined with a
ne nasal
decongestant for
the treatment of
symptoms
associated with
seasonal allergic
rhinitis and
sinusitis.
Levocetrizine It is indicated in Rincit  Tablets Vie
adults and w
children over 6
years of age for
the treatment of
symptoms
associated with
allergic
conditions such
as (a) Seasonal
allergic rhinitis
(including ocular
symptoms). (b)
Perennial allergic
rhinitis. (c)
Chronic
idiopathic
urticaria.

Loratadine It is indicated for Allerget  Syrup Vie

the symptomatic Tablets w
relief of Glora 
symptoms
associated with
seasonal and
perennial
allergic rhinitis
such as
sneezing, nasal
discharge and
itching and
ocular itching
and burning. It
is also indicated
for relief of
symptoms and
signs of chronic
 urticaria and
other allergic
dermatological
disorders.

Antihyperlipidemics

Vie
Generic w
Indication Brands Form
Name Det
ail

Simvastatin It is indicated for Simvog Tablets Vie

(a) Patients with et  w
Hypercholesterol
emia requiring
Modifications of
Lipid Profiles.
(b) Adolescent
Patients with
Heterozygous
Familial
Hypercholesterol
emia (HeFH).

Antihypertensive & Antilipidemic

Vie
Generic w
Indication Brands Form
Name Det
ail

Amlodipine + It is indicated in Ampige Tablets Vie

Atorvastatin patients for t  w
whom treatment Cadwin 
with both
amlodipine and
atorvastatin is
 appropriate. It is
used to treat
patients with
hyperlipidemia
and either
hypertension or
angina

Anxiolytics

Vie
Generic w
Indication Brands Form
Name Det
ail

Alprazolam For the relief of Praz  Tablets Vie

anxiety, w
nervousness,
and tension
associated with
anxiety
disorders. Also
used to treat
panic disorders.

Calcium Supplements

Vie
Generic w
Indication Brands Form
Name Det
ail

Ossein mineral It is indicated for Osam  Tablets Vie

complex the treatment w
of: Increased
mineral
requirements
during
 pregnancy and
lactation;
osteoporosis;
osteomalacia;
prophylaxis
against dental
caries; as
adjuvant in
fractures with
delayed callus
formation.

Ossein Mineral It is indicated for Osam-D  Tablets Vie

Complex + the treatment w
Vitamin D of: Increased
mineral
requirements
during
pregnancy and
lactation,
osteoporosis,
osteomalacia,
osteoarthritis,
rickets, bone
pain, bone
fragility,
stiffness in the
joints, fatigue,
hypocalcemia,
prophylaxis
against dental
caries and as an
adjuvant in
fractures with
delayed callus
formation.

Hematinic
 Vie
Generic w
Indication Brands Form
Name Det
ail

Iron (III)- It is indicated Ferfix  Syrup Vie

hydroxide for: The w
polymaltose treatment of
complex latent iron
deficiency;
manifest iron
deficiency;
prophylactic
therapy of iron
deficiency
before, during
and after
pregnancy
(during
lactation).

Iron (III)- It is indicated Ferfix- Tablets Vie

hydroxide for: The FA  w
polymaltose treatment of
complex + latent iron
Folic acid deficiency;
manifest iron
deficiency;
prophylactic
therapy of iron
and folic acid
deficiency before
during and after
pregnancy
(during
lactation).
Iron Sucrose Ferotein-S is Ferotein IV Vie
indicated for the -S  w
treatment of
iron deficiency
when there is a
clinical need to
deliver iron
rapidly to iron
stores, Patients
who cannot
tolerate oral iron
therapy or who
are non-
compliant, In
active
inflammatory
bowel disease
where oil iron
preparations are
in effective,
Non-dialysis
dependent-
chronic kidney
disease, Patients
receiving an
erythropoietin,
Non-dialysis
dependent-
chronic kidney
disease, Patients
not receiving an
erythropoietin,
Hemodialysis
dependent
chronic kidney
disease, Patients
receiving an
 erythropoietin,
Peritoneal
dialysis
dependent-
chronic kidney
disease, Patients
receiving an
erythropoietin.

Hepatic Protector Lipotropics

Vie
Generic w
Indication Brands Form
Name Det
ail

Silymarin It is indicated Heprote Tablets Vie

for, (a) the c  w
protection of the Sym 
liver from
toxins, heavy
metals, alcohol
and poisons. (b)
Liver disease,
acute and
chronic
hepatitis. (c)
Treatment of
fatty
degeneration of
the liver, liver
cirrhosis. (d).
Psoriasis. (e)
Gall bladder
disorders. (f)
Indigestion. It
also protects the
 liver from
damages caused
by general
anesthesia

Immunomodulators

Vie
Generic w
Indication Brands Form
Name Det
ail

Interferon - For the Unifero Injection Vie

Alfa 2b treatment of n  w
HCV and HBV
infections in
adults and
children who are
at risk of liver
disease. In HCV
interferon-Alfa
2b is used in
combination
with ribavirin.

Peginterferon Chronic hepatitis Unipeg  Injection Vie

alfa-2a C: Treatment of w
chronic hepatitis
C in adult
patients who are
positive for
serum HCV-RNA,
including
patients with
compensated
cirrhosis and/or
co-infected with
clinically stable
 HIV. Chronic
hepatitis B:
Treatment of
HBeAg-positive
or HBeAg-
negative-chronic
hepatitis B in
adult patients
with
compensated
liver disease and
evidence of viral
replication,
increased ALT
and
histologically
verified liver
inflammation
and/or fibrosis.

Laxatives

Vie
Generic w
Indication Brands Form
Name Det
ail

Lactulose Drug for the Lilac  Syrup Vie

treatment of w
constipation.

Urinary Antispasmodic

Vie
Generic w
Indication Brands Form
Name Det
ail
Solifenacin For the Solifen  Tablets Vie
treatment of w
overactive
bladder with
symptoms of
urge urinary
incontinence,
urgency and
urinary
frequency or
frequent
micturition.

Urogenital/Antispasmodics(Alpha1-A Adrenoreceptor Antagonist)

Vie
Generic w
Indication Brands Form
Name Det
ail

Tamsulosin It is used for the Tamsoli Capsules Vie

HCl treatment of the n  w
signs and
symptoms of
benign prostatic
hyperplasia
(BPH)

Vitamin B12 Analogue

Vie
Generic w
Indication Brands Form
Name Det
ail

Mecobalamin It is indicated for Nervon  IV Vie

the treatment Tablets w
of: Peripheral
 neuropathies;
Megaloblastic
anemia caused
by Vitamin B12
deficiency.

Vitamin D Analogue

Vie
Generic w
Indication Brands Form
Name Det
ail

Alfacalcidol Alfacalcidol is Adela  Tablets

used for treating
conditions in
which calcium
metabolism is
disturbed due to
impaired 1
alpha-
hydroxylation,
such as reduced
renal function
and in other
disorders
associated with
Vitamin D
resistance.